RQ Biotechnology Limited
PrivateLast Round
Series A
Jun 24, 2026
Total Funding Raised
$230M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
RQ Biotechnology Limited is a biotechnology company that develops potent, broad-spectrum monoclonal antibodies to provide passive immunization against viral infections for vulnerable populations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RQ Biotechnology Limited Comparables
Compare RQ Biotechnology Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NorthLinks Bio | 74% | |
| AstraZeneca | 71% | |
| Merck & Co., Inc. | 68% |
RQ Biotechnology Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 24, 2026 | ||||
| Series A | Jun 24, 2024 |
Key People
Founding team and executive leadership
RQ Biotechnology Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series A |
| Forbion | Series A |
| Oxford Science Enterprises | Series A |
| Monograph Capital | Series A |
| University of Oxford | Series A |
| Frazier Life Sciences | Series A |
| LifeArc Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 7, 2026
Open roles increased to 5, 5x the trailing average.
- Aug 24, 2026
Open roles increased to 4, representing 25% of headcount.
Recent news
Latest coverage and updates
- hiresJun 24, 2026
RQ Biotechnology Ltd. hired Joe Cabral as Board of Directors on Jun 24th '26.
- hiresJun 24, 2026
RQ Biotechnology Ltd. hired Christian S. Schade as Executive Chairman on Jun 24th '26.
- receives_financingJun 24, 2026
RQ Biotechnology Ltd. received financing of $115M in Series A on Jun 24th '26.
RQ Biotechnology Limited Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RQ Biotechnology Limited's valuation, stock price, and market status.
Is RQ Biotechnology Limited a public or private company?
RQ Biotechnology Limited is a private company.
What is the current stock price of RQ Biotechnology Limited?
RQ Biotechnology Limited is a private company with no public stock price. No recent secondary market data is available.
How much is RQ Biotechnology Limited worth (valuation)?
Valuation information for RQ Biotechnology Limited is not publicly available.
Can I buy RQ Biotechnology Limited stock?
RQ Biotechnology Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RQ Biotechnology Limited's last funding round?
RQ Biotechnology Limited's most recent funding round was Series A on June 24, 2026.
Who are the main investors in RQ Biotechnology Limited?
Key investors in RQ Biotechnology Limited include Frazier Life Sciences.
Will RQ Biotechnology Limited IPO soon?
No public IPO plans have been announced for RQ Biotechnology Limited.
How can I track RQ Biotechnology Limited secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RQ Biotechnology Limited's secondary market activity and sign up for updates.